Advertisement covers The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012)

52nd International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 9-12 September 2012, San Francisco

September/October 2012

The annual ICAAC conferences tend to have such a reduced focus on HIV in recent years that i-Base rarely prioritises attending this meeting.

Also, unlike most HIV meetings, only limited access is provided to abstracts and presentations. This is not a good model for health news. Some reports are restricted to data that was included in the abstract which have very limited peer review.

So the few articles included in this issue are to highlight potentially interesting studies that will hopefully be presented with greater detail and better access at either the HIV Congress in Glasgow in November, or at CROI in Atlanta in March next year.

For a limited period, abstracts and sessions can be searched and browsed online:

Despite their short access period and tediously long URLs, links to abstracts are included in each report.

PowerPoint slides from selected studies are also posted to the free-access which includes approximately 50 reports from ICAAC.

Reports in this issue of HTB are:

This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. Visit HIV i-Base's website to find out more about their activities, publications and services.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.